SciELO - Scientific Electronic Library Online

 
vol.43 issue4Decrease in the intensive care unit-acquired weakness with a multicomponent protocol implementation: A quasi-experimental clinical trialUpdate of antimicrobial resistance in level III and IV health institutions in Colombia between January 2018 and December 2021 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Biomédica

Print version ISSN 0120-4157On-line version ISSN 2590-7379

Abstract

PUERTO, Gloria Mercedes et al. Drug-resistant tuberculosis in Colombia, 2013-2018: Case-control study. Biomed. [online]. 2023, vol.43, n.4, pp.447-456.  Epub Dec 01, 2023. ISSN 0120-4157.  https://doi.org/10.7705/biomedica.6842.

Introduction.

Multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is difficult to control, has high morbidity and mortality, and demands priority public health intervention. In Colombia, MDR/RR-TB has been becoming more widespread annually. Before the COVID-19 pandemic, over an 8-year period, the number of cases of multidrug-resistant tuberculosis in Colombia was close to a thousand cases. Timely identification of the different risk factors for MDR/RR-TB will contribute fundamentally to the systematic management.

Objective.

To determine which risk factors were associated with the presentation of MDR in Colombia between 2013 and 2018.

Materials and methods.

A retrospective case-control study was carried out, for which the data from the routine surveillance of MDR/events in the country were used.

Results.

The cases of multidrug-resistant tuberculosis were mainly in young people, Afrodescendants, and males. Of the clinical conditions, comorbidities such as malnutrition, diabetes, and HIV, presence of at least one factor, such as drug dependence, taking immunosuppressive medications, belonging to the black race, afro, and living in an area of high disease burden were risk factors.

Conclusion.

In addition to the diagnosis and timely provision of MDR-TB treatment, it is necessary that public health programs at the local level pay special attention to patients with the identified risk factors.

Keywords : tuberculosis; drug resistance, multiple; risk factors; retrospective studies; comorbidities; case-control studies; black people.

        · abstract in Spanish     · text in English     · English ( pdf )